21Muscat S, Parks S, Kemp E, Keating D: Secondary retinal changes associated with choroidal naevi and melanomas documented by optical coherence tomography. Br J Ophthalmol 2004;88:120–124.
22Espinoza G, Rosenblatt B, Harbour JW: Optical coherence tomography in the evaluation of retinal changes associated with suspicious choroidal melanocytic tumors. Am J Ophthalmol 2004;137:90–95.
23Singh AD, Belfort RN, Sayanagi K, Kaiser PK: Fourier domain optical coherence tomographic and auto-fluorescence findings in indeterminate choroidal melanocytic lesions. Br J Ophthalmol 2010;94:474–478.
24Shields CL, Kaliki S, Rojanaporn D, et al: Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus. Arch Ophthalmol 2012;130:850–856.
25Shields CL, Pellegrini M, Ferenczy SR, Shields JA: Enhanced depth imaging optical coherence tomography of intraocular tumors. From placid to seasick to rock and rolling topography – the 2013 Francesco Orzalesi Lecture. Retina 2014;34:1495–1512.
26Mrejen S, Fung AT, Silverman RH, et al: Potential pitfalls in measuring the thickness of small choroidal melanocytic tumors with ultrasonography. Retina 2013;33:1293–1299.
27Horgan N, Shields CL, Mashayekhi A, et al: Early macular morphological changes following plaque radiotherapy for uveal melanoma. Retina 2008;28:263–273.
28Jia Y, Tan O, Tokayer J, et al: Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 2012;20:4710–5725.
29Spaide RF, Klancnik JM, Cooney MJ: Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 2015;133:45–50.
30Chang AE, Karnell LH, Menck HR: The National Cancer Data Base report on cutaneous and noncutaneou s melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664–1678.
31Shields CL, Kaliki S, Furuta M, et al: Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina 2012;32:1363–1372.
32Singh AD, Topham A: Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 2003;110:956–961.
33Mashayekhi A, Schonbach E, Shields CL, Shields JA: Early subclinical macular edema in eyes with uveal melanoma: association with future cystoid macular edema. Ophthalmology 2015;122:1023–1029.
34Shields CL, Say EAT, Samara WA, et al: Optical coherence tomography angiography of the macula after plaque radiotherapy of choroidal melanoma: comparison of irradiated versus nonirradiated eyes in 65 patients. Retina 2016;36:1493–1505.
35Say EAT, Samara WA, Khoo CT, et al: Parafoveal capillary density after plaque radiotherapy for choroidal melanoma. Analysis of eyes without radiation maculopathy. Retina 2016;36:1670–1678.
36Li Y, Say EAT, Ferenczy SR, et al: Altered parafoveal microvasculature in treatment-naïve choroidal melanoma eyes detected by optical coherence tomography angiography. Retina 2017;37:32–40.
37Valverde-Megias A, Say EAT, Ferenczy SR, Shields CL: Differential macular features on optical coherence tomography angiography in eyes with choroidal nevus and melanoma. Retina 2017;37:731–740.
38Bhardwal S, Tsui E, Zahid S, et al: Value of fractal analysis of optical coherence tomography angiography in various stages of diabetic retinopathy. Retina 2018;38:1816–1823.
39Gadde SGK, Anegondi N, Bhanushali D, et al: Quantification of vessel density in retinal optical coherence tomography angiography images using local fractal dimension. Invest Ophthalmol Vis Sci 2016;57:246–252.
40Matet A, Daruich A, Zografos L: Radiation maculopathy after proton beam therapy for uveal melanoma: optical coherence tomography angiography alterations influencing visual acuity. Invest Ophthalmol Vis Sci 2017;58:3851–3861.
41Han IC, Jaffe GJ: Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology 2010;117:1177–1189.
42Chhablani J, Krishnan T, Sethi V, Kozak I: Artifacts in optical coherence tomography. Saudi J Ophthalmol 2014;28:81–87.
43Spaide RF, Fujimoto JG, Waheed NK: Image artifacts in optical coherence tomography angiography. Retina 2015;35:2163–2180.
44de Carlo TE, Romano A, Waheed NK, Duker JS: A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous 2015;1:5–20.
45Say EAT, Ferenczy SR, Magrath GN, et al: Image quality and artifacts on optical coherence tomography angiography: comparison of pathologic and paired fellow eyes in 65 patients with unilateral choroidal melanoma treated with plaque radiotherapy. Retina 2017;37:1660–1673.
46Cennamo G, Romano MR, Breve MA, et al: Evaluation of choroidal tumors with optical coherence tomography. Enhanced depth imaging and OCT-angiography features. Eye 2017;31:906–915.
47Nesper PL, Lutty GA, Fawzi AA: Residual choroidal vessels in atrophy can masquerade as choroidal neovascularization on optical coherence tomography angiography. Retina 2018;38:1289–1300.
48Missotten GS, Notting IC, Schlingemann R, et al: Vascular endothelial growth factor A in eyes with uveal melanoma. Arch Ophthalmol 2006;124:1428–1434.
49Vinores SA, Küchle M, Mahlow J, et al: Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol 1995;147:1289–1297.
50Boyd SR, Tan D, Bunce C, et al: Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol 2002;86:448–452.
51Koulisis
